Insider Sells 22000 Shares of Cabaletta Bio in Major Transaction
May 25, 2023
Trending News ☀️
TRANSACTION ($TSE:7818): Recently, an insider of Cabaletta Bio Inc. made a major transaction by selling off 22000 shares of its stock. Cabaletta Bio Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for the treatment of autoimmune and inflammatory diseases. It has a pipeline of product candidates targeting a variety of therapeutic areas, including rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis. The recent transaction marks the third largest insider transaction this year and is expected to have a significant impact on the stock price.
Cabaletta Bio Inc.’s stock has been volatile over the past few weeks, so it will be interesting to see how the recent insider sale influences its performance in the market. Analysts remain cautiously optimistic about the company’s performance as it continues to expand its product portfolio.
Stock Price
The stock opened at JP¥1747.0 and closed at the same price, representing a 0.9% increase from the previous closing price of 1731.0. While the details of this transaction are not clear, the insider’s decision has certainly had an impact on the company’s stock. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Transaction. More…
| Total Revenues | Net Income | Net Margin |
| 20.58k | 2.68k | 13.0% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Transaction. More…
| Operations | Investing | Financing |
| 1.07k | -1.4k | -481.3 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Transaction. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 17.87k | 3.81k | 483.23 |
Key Ratios Snapshot
Some of the financial key ratios for Transaction are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 7.1% | 22.6% | 19.7% |
| FCF Margin | ROE | ROA |
| 4.5% | 18.5% | 14.2% |
Analysis
At GoodWhale, we believe in helping our users make informed decisions when it comes to their investments. That’s why we’ve done a thorough analysis of TRANSACTION‘s financials to give our users an in-depth look at the company. Based on our Risk Rating, TRANSACTION is a high risk investment in terms of financial and business aspects. We have detected 3 risk warnings in their income sheet, balance sheet, and cashflow statement. To access this information, become a registered user so you can take a closer look at their finances. More…
Peers
The competition between TRANSACTION Co Ltd and its competitors is fierce and ongoing. Four notable competitors include Fayenceries de Sarreguemines, Chongqing Baiya Sanitary Products Co Ltd, and Seihyo Co Ltd, all of whom are vying for the top spot in the industry. While each of these companies have their own unique strategies and offerings, TRANSACTION Co Ltd is determined to come out on top.
– Fayenceries de Sarreguemines ($LTS:0NAE)
Fayenceries de Sarreguemines is a French manufacturer of ceramic tableware and decorative objects. The company has a market cap of 4.41 million as of 2023, which indicates that it is a small to mid-sized enterprise. The company has experienced steady growth since its inception in 1797, and today produces a wide range of ceramic products for both domestic and international markets. It is known for its quality craftsmanship, having produced several iconic pieces such as the green-and-white striped majolica plates, which are especially popular in France. The company also works with renowned designers to create unique pieces for the modern home.
– Chongqing Baiya Sanitary Products Co Ltd ($SZSE:003006)
Chongqing Baiya Sanitary Products Co Ltd is a Chinese manufacturer and distributor of hygiene and sanitation products. The company has a market cap of 6.57 billion, as of 2023, making it one of the largest and most successful companies in this sector. It also has a Return on Equity (ROE) of 10.18%, indicating that the company is generating significant profits from its shareholders’ investments. With its innovative products, wide distribution network and strong financial performance, Chongqing Baiya Sanitary Products Co Ltd is well-positioned to continue to grow and expand its market share.
– Seihyo Co Ltd ($TSE:2872)
Seihyo Co Ltd is a Japanese company that specializes in the manufacture of energy efficient lighting and other electrical products. The company has a market capitalization of 5.97 billion as of 2023, which makes it one of the largest companies in the industry. Additionally, Seihyo Co Ltd has a Return on Equity of 0.18%. This indicates that the company is able to generate profit efficiently, which is indicative of strong management and financial stability.
Summary
Investors should take note of the recent insider transaction involving Cabaletta Bio Inc. stock. Such transactions can be indicative of the insider’s view on the stock’s performance or their own need for the funds. It is important to consider this type of activity when making investment decisions, as it could signal a shift in sentiment and provide insight into potential future market movements.
Related Posts
Recent Posts
